UNSPSC 51373476: Hydrocodone/potassium guaiacolsulfonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373476 Hydrocodone/potassium guaiacolsulfonate is a Commodity code that in practice covers pharmaceutical products and controlled-substance pharmaceuticals supplied to state and local public health and correctional facilities. Recent solicitations under this code reflect demand for parenteral products (intravenous solutions, nutrition preparations, and related equipment) and opioid-antagonist medications (naloxone) delivered to correctional systems and county health departments on recurring, multi-year contracts with strict delivery windows and cold-chain or time-sensitive handling requirements. State and local issuers soliciting under this code include state departments of corrections and county public health and community health organizations. The Washington State Department of Corrections is a repeat buyer, procuring parenteral products and services across eight correctional facilities with contracts running multiple years and provisions for multi-vendor regional awards.

Activity appears concentrated in the Pacific Northwest and Southeast. The Washington State Department of Corrections issued RFQ RFQQK13020 for parenteral products, services, and equipment on September 8, 2026, with bids due October 7, 2026 and pre-bid conference on September 23, 2026; the scope includes TPN and PPN solutions, intravenous products, and controlled substances for incarcerated individuals, with delivery requirements of 24 hours for nutritional preparations and 8 hours for other parenteral products to facilities in three geographic regions (West, Central, and East Washington). Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building. The Washington procurement includes set-aside preferences for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with aspirational diverse-business goals; both solicitations require compliance with state-specific business licensing, NCIC clearance or E-Verify, and specified insurance coverage.